A Competent and Commercially Viable Process for the Synthesis of the Anti-Hypertensive Drug Olmesartan Medoxomil

Drug product purity and potency are of most significance in the regulatory market as we notice many recalled batches worldwide, particularly in the US and Japan. Olmesartan Medoxomil is an anti-hypertensive drug. The present invention relates to a process for the preparation of Olmesartan Medoxomil...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanumantha Rao, Bommena, Subramanyeswara Rao, Inti Venkata, Ravi Kanth, Vysyaraju, Prasada Rao, Korrapati Venkata Vara, Balamurali Krishna, K., Syama Sundar, Bethanabatla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Austrian Journal of Pharmaceutical Sciences 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727774/
https://www.ncbi.nlm.nih.gov/pubmed/26839831
http://dx.doi.org/10.3797/scipharm.1502-04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727774/
https://www.ncbi.nlm.nih.gov/pubmed/26839831
http://dx.doi.org/10.3797/scipharm.1502-04

Ejemplares similares